Shire Takes Aim At Mylan Again In New Intuniv Patent Suit
Shire LLC slapped Mylan Inc. with another patent suit over the attention deficit hyperactivity disorder drug Intuniv in West Virginia federal court Thursday, after Mylan changed its bid for regulatory approval...To view the full article, register now.
Already a subscriber? Click here to view full article